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Engagement of the TCR triggers sustained Ca
 
2
 
 
 
 entry through Ca
 
2
 
 
 
 release-activated Ca
 
2
 
 
 
 
(CRAC) channels, which helps drive gene expression underlying the T cell response to 
pathogens. The identity and activation mechanism of CRAC channels at a molecular level are 
unknown. We have analyzed ion channel expression and function in T cells from SCID 
patients which display 1–2% of the normal level of Ca
 
2
 
 
 
 influx and severely impaired T cell 
activation. The lack of Ca
 
2
 
 
 
 influx is not due to deficient regulation of Ca
 
2
 
 
 
 stores or 
expression of several genes implicated in controlling Ca
 
2
 
 
 
 entry in lymphocytes (
 
kcna3/
 
Kv1.3, 
 
kcnn4
 
/IKCa1, 
 
trpc1
 
, 
 
trpc3
 
, 
 
trpv6
 
, 
 
stim1
 
). Instead, electrophysiologic measurements show that 
the influx defect is due to a nearly complete absence of functional CRAC channels. The lack 
of CRAC channel activity is correlated with diminished voltage sensitivity and slowed 
activation kinetics of the voltage-dependent Kv1.3 channel. These results demonstrate that 
CRAC channels provide the major, if not sole, pathway for Ca
 
2
 
 
 
 entry activated by the TCR in 
human T cells. They also offer evidence for a functional link between CRAC and Kv1.3 
channels, and establish a model system for molecular genetic studies of the CRAC channel.
 
Ca
 
2
 
 
 
 has an essential role during development
and for the mature function of lymphocytes.
In mature T lymphocytes, presentation of anti-
gen triggers a coordinated series of events cul-
minating in cell activation and proliferation.
One of the earliest biochemical steps in this
process is the activation of phospholipase C
(PLC)
 
 
 
, which generates inositol-1,4,5 tris-
phosphate, releasing Ca
 
2
 
 
 
 from the ER. The
resulting decrease in lumenal ER Ca
 
2
 
 
 
 triggers
Ca
 
2
 
 
 
 influx by opening a class of store-operated
Ca
 
2
 
 
 
 channels in the plasma membrane,
known as Ca
 
2
 
 
 
 release-activated Ca
 
2
 
 
 
 (CRAC)
channels (1–3). The ensuing sustained [Ca
 
2
 
 
 
]
 
i
 
elevation activates transcriptional pathways re-
quired for proliferation and effector immune
function. Ca
 
2
 
 
 
 also has an essential role in T
cell development, by influencing thymocyte
motility and positive selection (4, 5). Pharma-
cologic, electrophysiologic, and genetic evidence
support the notion that CRAC channels are
the principal pathway for Ca
 
2
 
 
 
 influx in devel-
oping and mature T cells, and thus, are likely
to orchestrate many aspects of lymphocyte devel-
opment and function (3). The importance of
store-operated Ca
 
2
 
 
 
 entry for immunologic
host defense is highlighted by the severe defi-
ciencies in T cell activation and effector gene
expression in patients lacking store-operated
Ca
 
2
 
 
 
 entry (6–8). Thus, understanding the
functional and molecular properties of CRAC
channels is central to a complete understanding
of T cell activation.
Several of the key downstream signaling
pathways triggered by CRAC channel activity
have been defined, but the molecular identity
of the CRAC channel and its activation mech-
anism remain elusive. Several candidate genes
belonging to the transient receptor potential
(TRP) family of ion channels have been pro-
posed to encode the CRAC channel, including
 
trpc1
 
 (9),
 
 trpc3
 
 (10), and 
 
trpv6
 
 (11, 12), as well
as voltage-gated Ca
 
2
 
 
 
 (Ca
 
V
 
) channels (13,
14). However, evidence that TRPs are store-
dependent following heterologous expression
in several cell lines is inconsistent (15, 16), and
none of the candidates exhibits all of the key
biophysical hallmarks of the CRAC channel:
lack of significant voltage-dependent gating, an
extremely high selectivity for Ca
 
2
 
 
 
 over mono-
valent  cations, extremely low single-channel
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conductance (
 
 
 
1 pS), inwardly rectifying current-voltage re-
lationship, rapid Ca
 
2
 
 
 
-dependent inactivation, blockade by
submicromolar La
 
3
 
 
 
, and modulation by 2-aminoethyldiphe-
nyl borate (2-APB; references 3, 17, 18). Thus, homomulti-
mers of these TRPs or Ca
 
V
 
 proteins are unlikely to make up
the native CRAC channel. Likewise, the nature of the signal
that links store depletion to channel activation is unknown,
despite a large number of proposed mechanisms (16).
Cells with a specific defect in the CRAC channel or its
activation process would provide a much-needed system for
elucidating the molecular basis of CRAC channel function.
We previously described two SCID patients with impaired
T cell activation arising from reduced activity of NFAT (19),
which was shown to result from a marked deficit in store-
operated Ca
 
2
 
 
 
 entry (8). In principle, this deficit could re-
flect abnormalities in any of several processes related to Ca
 
2
 
 
 
influx, including ER Ca
 
2
 
 
 
 store regulation and the activity
of K
 
 
 
 channels in addition to CRAC channels themselves.
K
 
 
 
 channels have long been known to play a critical role in
early events in T cell activation, most likely by maintaining a
negative resting potential that provides the electrical driving
force for Ca
 
2
 
 
 
 entry (20). Pharmacologic blockade of K
 
 
 
channels profoundly inhibits T cell activation, an effect that
has been ascribed to membrane depolarization and a conse-
quent reduction of the driving force for Ca
 
2
 
 
 
 entry through
CRAC channels (21). Here we show that the lack of Ca
 
2
 
 
 
signaling results directly from a selective absence of CRAC
channel activity, most likely due to aberrant CRAC channel
regulation. Expression of other channels, including TRPC1,
TRPC3, TRPV6, TRPM7, and the K
 
 
 
 channels, IKCa1
and Kv1.3, is normal. However, the gating properties of the
voltage-gated K
 
 
 
 channel Kv1.3 are altered in the SCID T
cells. Collectively, these results establish the SCID T cells as
a model system for identifying molecules involved in CRAC
channel activation, and reveal a possible functional link be-
tween CRAC channels and K
 
 
 
 channel gating.
 
RESULTS
Store-operated Ca
 
2
 
 
 
 entry is deficient in SCID cells despite 
normal Ca
 
2
 
 
 
 release from stores
 
We previously described a Ca
 
2
 
 
 
 signaling defect in T lym-
phocytes from patients with a SCID (8, 19, 22). This defect
nearly abolished Ca
 
2
 
 
 
 influx in the SCID T cells following
activation of TCR and after passive depletion of intracellular
Ca
 
2
 
 
 
 stores with thapsigargin (TG) or ionomycin. Because
Ca
 
2
 
 
 
 store depletion is necessary for any of these stimuli to
activate Ca
 
2
 
 
 
 influx through CRAC channels, we asked
whether Ca
 
2
 
 
 
 stores are abnormal in the SCID T cells—
either in their content or their ability to release Ca
 
2
 
 
 
. Treat-
ment of SCID T cells with anti-CD3 mAb (Fig. 1 A) or TG
(Fig. 1 B) in the absence of extracellular Ca
 
2
 
 
 
 evoked the
normal extent of Ca
 
2
 
 
 
 release from intracellular stores com-
pared with control T cells from healthy individuals, as mea-
sured by the amplitude and kinetics of the [Ca
 
2
 
 
 
]
 
i
 
 increase.
In both cases, readdition of 2 mM Ca
 
2
 
 
 
o
 
 to the SCID T cells
failed to elicit significant Ca
 
2
 
 
 
 influx compared with control
cells, as documented previously (8). Thus, the defect in Ca
 
2
 
 
 
influx is not the result of aberrant Ca
 
2
 
 
 
 store depletion in the
SCID T cells.
Consistent with these results, the expression of PLC
 
 
 
1
and 
 
 
 
2 and inositol-1,4,5 trisphosphate receptors—proteins
that link TCR stimulation to store depletion—in SCID T
cells was within the range of protein expression in control T
cells (Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20050687/DC1). Together, these results demon-
strate normal operation of the Ca
 
2
 
 
 
 signaling machinery
leading from TCR engagement to Ca
 
2
 
 
 
 release from the
ER, and suggest that the absence of store-operated Ca
 
2
 
 
 
 in-
flux in the SCID T cells is due to a defect downstream of
Ca
 
2
 
 
 
 store depletion.
 
Store depletion fails to activate CRAC channels in SCID T cells
 
In principle, several mechanisms could abrogate Ca
 
2
 
 
 
 influx
subsequent to store depletion. These include defective ex-
pression or function of store-operated CRAC channels, as
well as less direct mechanisms involving depolarization of
the cell’s membrane potential and consequent reduction of
the driving force for Ca
 
2
 
 
 
 entry. To distinguish between
these possibilities, we directly measured CRAC channel
function in SCID patients and control T cells using the
whole-cell patch-clamp technique.
Control and SCID T cells were pretreated with 1 
 
 
 
M
TG for 15 min to deplete Ca
 
2
 
 
 
 stores completely. Subse-
Figure 1. Ca2  store depletion fails to activate significant Ca2  
entry in T cells from SCID patients. (A) Intracellular Ca2  release and 
influx in response to CD3 cross-linking in T cells from healthy controls 
(black trace; n   30 cells) and SCID patients (red trace; n   30 cells). 
Biotinylated anti-CD3 antibody (5  g/ml) was cross-linked with streptavidin 
(5  g/ml) as indicated in the absence of extracellular Ca2  to measure 
intracellular Ca2  release, followed by addition of 2 mM Ca2  to measure 
influx. (B) Ca2  release and influx stimulated by TG (1  M) in T cells from 
healthy controls (black trace; n   30 cells) and SCID patients (red trace; 
n   30 cells). In both experiments, Ca2  influx in SCID cells largely is absent 
despite normal release of Ca2  from stores.JEM VOL. 202, September 5, 2005 653
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quent exposure of control T cells to 20 mM Ca2  produced
an inward Ca2  current in 5/5 cells (Fig. 2 A), which was
identified as CRAC current (ICRAC) based on several key
characteristics. First, the response to rapid voltage ramps
showed an inwardly rectifying current-voltage relationship
and lack of an obvious reversal potential, both of which are
typical of ICRAC (Fig. 2 B). Second, as previously shown for
ICRAC in Jurkat T cells (23), the Ca2  current in normal hu-
man T cells was potentiated strongly by 5  M 2-APB
(240   45% enhancement; n   4 cells; Fig. 2 C). Third, re-
moval of all extracellular Ca2  and Mg2  by application of a
divalent-free (DVF) solution produced an inward Na  cur-
rent that initially was approximately eightfold larger than the
preceding Ca2  current, and slowly declined by  90% (Fig.
2 A). It is well known that removal of divalent cations allows
Na  to permeate CRAC channels but does not sustain their
activity, leading to a slow rundown of the current in Jurkat
T cells (24, 25) and RBL cells (26).
In contrast to the control cells, TG-pretreated SCID T
cells exhibited no detectable ICRAC in 20 mM Ca2 
o (Fig. 2,
D and E; 6/6 cells). Currents were not increased, even after
removal of extracellular divalent cations (Fig. 2, D and G) or
after treatment with 5  M 2-APB (Fig. 2 F), two conditions
that greatly enhance the sensitivity for detecting current
through normal CRAC channels. These results directly
demonstrate an extreme lack of functional CRAC channels
in the SCID T cells that can account for the profound de-
fects in Ca2  influx observed after stimulation through the
TCR or after passive store depletion.
Residual Ca2  influx in SCID T cells: evidence for a defect 
in CRAC channel activation
The absence of CRAC channel activity in SCID T cells
could arise from two potential sources: aberrant expression
of CRAC channels (e.g., a null mutation in the structural
gene for the channel or faulty trafficking to the plasma mem-
brane) or defective activation of CRAC channels in response
to store depletion. Clues that distinguish between these
mechanisms came from observations of residual Ca2  influx
in the presence of high extracellular Ca2  levels. Although
store-depleted SCID cells fail to display detectable ICRAC and
lack Ca2  influx in 2 mM Ca2 
o, they do exhibit a small de-
gree of Ca2  influx in the presence of 20 mM Ca2 
o. This
influx occurred in all SCID cells, and evoked a transient in-
crease in [Ca2 ]i (Fig. 3 A). The initial slope of the [Ca2 ]i
increase was measured as an indicator of the apparent Ca2 
Figure 2. Functional CRAC channels are undetectable in whole-cell 
patch-clamp recordings from SCID T cells. (A) Ca2  and Na  currents 
through CRAC channels in a control T cell. Peak currents recorded every 1.5 s 
during brief steps to  110 mV are shown. Exposure of this TG-pretreated 
cell to 20 mM Ca2  evoked an inward CRAC Ca2  current, whereas subse-
quent exposure to DVF solution allowed Na  to carry an approximately 
eightfold larger inward current that declined slowly due to depotentiation. 
(B) Current-voltage relationship of the CRAC Ca2  current. The graph shows 
the average of 10 leak-corrected responses to voltage ramps recorded from 
78–92 s shown by the gray bar in A. (C) 2-APB strongly enhanced ICRAC. After 
development of ICRAC, 5  M 2-APB was applied as indicated. Peak currents at 
 110 mV plotted as in A. (D) CRAC Ca2  and Na  currents were absent in 
SCID T cells. Same protocol as in A. (E) Current-voltage relationship of the 
current recorded in D. (F) Application of 5  M 2-APB failed to elicit a 
response in the SCID cells. (G) Summary of the Ca2  (ICRAC) and Na  (IDVF) 
current densities in control (Ca2  current: n   5 cells; Na  current: n   4 
cells) and SCID (Ca2  current: n   6 cells; Na  current: n   4 cells) T cells 
normalized to the capacitance of each cell (a measure of surface area).CRAC CHANNEL DEFECT IN SCID T CELLS | Feske et al. 654
influx rate, which in SCID cells was 1–2% of the rate ob-
served in control T cells under similar conditions (Fig.
S2 A, available at http://www.jem.org/cgi/content/full/
jem.20050687/DC1). The transient time course of the re-
sponse is similar to that observed in TG-treated normal Jur-
kat T cells after initiating influx with low concentration of
Ca2 
o (27); most likely this is due to a slow increase in Ca2 
extrusion by the plasma membrane Ca2 -ATPase (PMCA),
because delayed modulation of PMCA has been shown to
create a transient [Ca2 ]i increase in response to constant
Ca2  influx through CRAC channels (28).
To examine whether the residual influx represents
CRAC channels or a different Ca2  influx pathway, we
tested its dependence on store depletion and its sensitivity to
CRAC channel inhibitors. Before store depletion by TG,
application of 20 mM Ca2 
o did not alter [Ca2 ]i in SCID T
cells (Fig. 3 A), indicating that the residual influx in TG-
treated cells depends on store depletion. A dose of 2-APB,
which fully inhibits ICRAC (75  M) (23), caused a rapid re-
turn of [Ca2 ]i to baseline when applied at the peak of the
Ca2  transient, indicating a complete inhibition of residual
Ca2  influx (Fig. 3 B). When 2-APB (75  M) was added at
the time of readdition of Ca2 , it completely blocked the re-
sidual Ca2  influx in the SCID T cells (Fig. S2 B). Likewise,
2  M La3  or 2  M Gd3  rapidly terminated residual Ca2 
influx (Fig. 3 C). Although La3  and Gd3  block several
types of ion channels, including many TRP channels, at low
 M concentrations these trivalent ions are relatively selec-
tive inhibitors of CRAC channels (29, 30). Finally, SKF
96365 (30  M), another inhibitor of CRAC channels (31),
accelerated the return of [Ca2 ]i to baseline when added near
the peak of the transient (unpublished data). This effect was
not as pronounced as the effect of 2-APB or trivalent cat-
ions, perhaps because inhibition of CRAC channels by SKF
96365 takes tens of seconds (31). For this reason, we also
added the drug  100 s before readdition of Ca2 , which
completely prevented the subsequent Ca2  influx response
(Fig. 3 D). Thus, the residual Ca2  influx is store-dependent
and displays several pharmacologic hallmarks of the CRAC
channel, suggesting that it arises from a small number of
open CRAC channels.
A distinctive property of CRAC channels is that their ac-
tivity is enhanced by low concentrations (1–5  M) of 2-APB
(23). Accordingly, 2-APB (3  M) added to control T cells
following Ca2  readdition caused a distinct further increase in
Ca2  influx was inhibited by Gd3  (green trace) or La3  (blue trace; 2  M). 
(D) Inhibition of residual Ca2  influx by SKF 96365. Application of SKF 
96365 (30  M) before readdition of Ca2  completely prevented the increase 
in [Ca2 ]i (blue trace). (E, F) A low concentration of 2-APB failed to enhance 
residual Ca2  influx in SCID T cells. (E) 3  M 2-APB enhanced Ca2  influx 
in control T cell (black trace), but did not affect the Ca2  transient in SCID 
cells (red trace). (F) 2-APB (5  M; blue trace) added with 20 mM Ca2  did 
not increase the Ca2  influx rate, as indicated by the initial slope (d[Ca2 ]i/dt), 
or the peak Ca2  response beyond that seen in untreated SCID T cells (red 
trace). Plots in A–F show the average and SEM values from 30 cells.
Figure 3. Residual Ca2  influx in SCID T cells is due to CRAC channels 
with an altered sensitivity to 2-APB. (A) Residual Ca2  influx in SCID 
cells is store-dependent. Exposure to 20 mM Ca2  before treatment with 
TG elicits a small [Ca2 ]i increase in control (black trace) but not SCID T 
cells (red trace). The small influx in control cells may reflect a low level of 
CRAC channel activity induced by previous incubation in 0 Ca2 . Following 
store depletion with TG, readdition of 20 mM Ca2  caused a small transient 
[Ca2 ]i increase in SCID T cells; the initial rising phase indicates an influx 
rate  1.5% of that in control T cells (also see Fig. S2 A). (B) Residual Ca2  
influx is sensitive to inhibition by a high concentration of 2-APB. Addition 
of 2-APB (75  M; blue trace) blocked Ca2  entry and caused [Ca2 ]i to 
decline rapidly in contrast to untreated SCID T cells (red trace). (C) Residual JEM VOL. 202, September 5, 2005 655
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[Ca2 ]i (Fig. 3 E). Given that the residual Ca2  influx in
SCID T cells displays several key properties of the CRAC
channel, it was surprising that 2-APB at low concentrations
( 5  M) failed to enhance residual influx when added near
the peak of the Ca2  transient (Fig. 3 E). A similar lack of ef-
fect was noted when 2-APB was added at a longer time
(240 s) following Ca2  readdition (unpublished data). To
maximize the detectability of a change in influx rate, we also
added 2-APB simultaneously with Ca2 ; under these condi-
tions, 2-APB also failed to enhance the rate of Ca2  influx in
SCID T cells (Fig. 3 F; 0.90 nM/s versus 0.87 nM/s with or
without 5  M 2-APB, respectively). The inability of low
concentrations of 2-APB to enhance residual Ca2  influx in
SCID cells cannot be explained by a defect that simply re-
duces the number of CRAC channels in the plasma mem-
brane, because a small number of normal channels in the
membrane would be expected to show normal enhancement
by 2-APB (e.g., see Fig. 2 C). Enhancement of ICRAC by
2-APB is believed to involve augmentation of the activation
process (32). Thus, an alternative explanation of our findings
is that the SCID cells have a primary defect in the CRAC
channel activation process, such that overall activity and en-
hancement are only 1–2% of the control level. Such a defect
in SCID cells could arise from abnormal generation or re-
sponse to the activation signal (see Discussion).
A primary defect in the activation, rather than the ex-
pression or targeting, of CRAC channels also is consistent
with a molecular analysis of potential CRAC channel genes
in the SCID cells. A variety of genes in the trp family, in-
cluding trpc1 (9), trpc3 (10), trpc4 (33), and trpv6 (11, 12) have
been proposed to form parts of store-operated Ca2  chan-
nels, in general, or the CRAC channel, in particular. We
found that transcripts for trpc1, c3, c4, c5, c7, trpv5, and v6, are
present in control T cells and at similar levels in SCID T
cells (Fig. S3, available at http://www.jem.org/cgi/content/
full/jem.20050687/DC1). In addition, no mutations were
detected in transcripts of trpc1, c3, m2, v5, or v6 amplified by
RT-PCR or in gene loci, including all known exons and
splice junctions for trpc3, c5, c6, m5, v5, and v6 using DNA
from both patients, their parents, one healthy brother, and
one independent control (unpublished data). Furthermore,
patients were heterozygous by haplotype mapping for the
Figure 4. The lack of store-operated Ca2  influx in SCID cells is 
independent of STIM1 expression. (A) STIM1 protein expression in SCID 
T cells. Whole-cell lysates from control and SCID patients’ T cells, Jurkat, 
and TE671 cells were immunoblotted with  STIM1 mAb, detecting a dom-
inant band at 80–85 kD. (B) Exogenous expression of STIM1 fails to rescue 
Ca2  influx in SCID fibroblasts. STIM1 was coexpressed with eGFP in fibro-
blasts from SCID patients (top panels). Virtually all cells expressing eGFP 
(green) showed a strong STIM1 signal (red) by immunocytochemistry. 48 h 
after transfection, cotransfected SCID fibroblasts were stimulated with 
TG (1  M) in the absence of Ca2  followed by readdition of 2 mM Ca2  
(bottom right). Mean Ca2  responses for GFP  (green) and GFP  (black) 
cells from the same experiment are shown. The Ca2  response in untrans-
fected control fibroblasts (bottom left) is shown for comparison. Results 
shown are representative of five experiments. (C) STIM1 shows a similar 
distribution in fibroblasts from SCID patients and controls. STIM1 was 
expressed in fibroblasts from one control and one SCID patient and protein 
localization detected by immunocytochemistry 48 h later. Merged images 
show substantial overlap of STIM1 and calreticulin indicating predominant 
localization of STIM1 in the ER in control and SCID fibroblasts. Images 
shown were obtained by deconvolution of an image z-stack.CRAC CHANNEL DEFECT IN SCID T CELLS | Feske et al. 656
region containing trpv5 and v6 genes on chromosome 7q31,
incompatible with the autosomal recessive mode of inherit-
ance in this disease (unpublished data). Finally, retrovirus-
based overexpression of myc-tagged TRPV6 failed to restore
TG- or TCR-triggered Ca2  influx in SCID T cells or TG-
triggered influx in fibroblasts (unpublished data). Collec-
tively, these observations lend further support to the notion
that the locus of the SCID defect involves the activation,
rather than the expression, of store-operated Ca2  channels.
Given the evidence for a regulatory defect in CRAC
channel activation, we examined the expression of stromal
interaction molecule (STIM)1, a conserved ER protein re-
cently shown to be essential for CRAC channel activation in
multiple cell types (34). Endogenous STIM1 protein levels in
T cells from SCID patients were comparable to those of con-
trol T cells and Jurkat cells (Fig. 4 A). In addition, no muta-
tions in STIM1 were apparent from sequencing genomic
DNA from the SCID patients. To test whether STIM1 over-
expression could rescue the Ca2  influx defect in cells from
the SCID patients, their fibroblasts were cotransfected with
pSTIM1 and GFP. Virtually all GFP  cells also expressed
STIM1 as determined by immunocytochemistry (Fig. 4 B).
However, GFP  cells did not show increased store-depen-
dent Ca2  influx compared with GFP  cells, which—like
untransfected SCID fibroblasts and T cells—are Ca2  influx
deficient (8). Despite the failure to rescue normal function,
STIM1 localization seemed to be similar in transfected SCID
and control fibroblasts (Fig. 4 C). Together, these results sug-
gest that the Ca2  influx defect is not due to inadequate ex-
pression of STIM1.
Specificity of the CRAC channel defect in SCID T cells
To address the specificity of the CRAC channel defect, we
applied patch-clamp techniques to measure the expression
and properties of other ion channels in SCID T cells, con-
centrating on channels known or believed to participate in
lymphocyte Ca2  signaling, such as TRPM7 and voltage-
gated and Ca2 -activated K  channels.
TRPM7 is a widely expressed Ca2 - and Mg2 -perme-
able ion channel (35, 36). Native TRPM7 channels in T
cells, called Mg2 -inhibited cation (MIC) channels or Mg2 
nucleotide-regulated metal channels typically are activated
by the washout of intracellular Mg2  and ATP during
whole-cell recording (25, 35). Because of their slow induc-
tion kinetics, MIC channels initially were confused with
CRAC channels; however, a variety of evidence argues that
they are molecularly distinct (25, 26, 37). In SCID and con-
trol T cells, introduction of intracellular Mg2 -free solutions
evoked the slow activation of currents with the properties of
MIC. As expected for IMIC, the currents showed outward
rectification in the presence of extracellular Ca2  and a linear
current-voltage relationship reversing around 0 mV in the
absence of external divalent ions (Fig. 5 A). The amplitude
and activation kinetics of MIC current in SCID T cells also
were similar to that of control T cells, demonstrating normal
MIC channel expression and properties (Fig. 5 B). The
nearly complete absence of ICRAC in these cells provides
strong genetic evidence that MIC and CRAC currents arise
from different gene products.
Human T cells express two classes of K  channels: the
voltage-gated Kv1.3 channel (encoded by the gene kcna3)
(38) and the Ca2 -activated IKCa1 channel (encoded by the
gene kcnn4) (39). Pharmacologic blockade of either type of
K  channel is known to inhibit Ca2  signaling and T cell
function, most likely by causing membrane depolarization
and a corresponding reduction in the driving force for Ca2 
entry (21). Therefore, it was conceivable that aberrant K 
channel function contributed to the defect in Ca2  influx in
the SCID T cells.
IKCa1 currents were evoked in SCID and control T
cells by intracellular dialysis with a buffered solution of 2
 M Ca2  in the presence of equal concentrations of intra-
cellular and extracellular K . IKCa1 current was identified
in response to voltage ramps from  100 to  100 mV by the
increased inward current at membrane potentials negative to
 50 mV; at more positive potentials, time- and voltage-
dependent activation of Kv1.3 sums with IKCa1 to produce
an “N”-shaped current-voltage relation (Fig. 6 A). The cur-
rent below  50 mV was blocked by 50 nM charybdotoxin
(CTX), as expected for IKCa1 channels (39, 40). With 2
 M Ca2  in the pipette solution, the current densities at
 100 mV were similar in the control and SCID T cells (Fig.
6 A, right panel), indicating normal IKCa1 expression and
function in SCID cells.
Kv1.3 currents were studied in detail using step depolar-
izations to elicit channel activation. Kv1.3 channels were
identified based on a collection of properties, including volt-
age-dependent activation; cumulative inactivation during a
series of repetitive depolarizations; and block by tetraethylam-
monium, CTX, and the highly selective inhibitor, Stichodac-
tyla helianthus (ShK) toxin (41). In all respects, the Kv current
in SCID cells was similar to Kv1.3 current in control T cells.
Both currents activated at potentials positive to –50 mV with
a similar current density (Fig. 6 B) and showed a similar rate
Figure 5. MIC/TRPM7 channels are normal in SCID T cells. (A) Current-
voltage relationships showing the typical permeation properties of MIC 
channels in control (left) and SCID T cells (right). Each graph show currents 
from one cell after 400 s of whole-cell recording in the presence of 20 mM 
Ca2  and shortly after removal of divalent ions (DVF solution). (B) Activation 
kinetics and magnitude of IMIC in SCID T cells are normal. The plot shows 
peak currents at  100 mV in the presence of 2 mM Ca2 
o in control (closed 
circles; n   4 cells) and SCID T cells (open circles; n   5 cells) as a function 
of time after break-in with Mg2 -free pipette solution.JEM VOL. 202, September 5, 2005 657
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and extent of cumulative inactivation during repetitive pulses
to  60 mV (Fig. 6 C). ShK-Dap22 toxin (200 pM) blocked
Kv currents in control and SCID T cells by 88   3% (n   5)
and 85   5% (n   6), respectively, consistent with a pub-
lished Ki of 23 pM (41). In addition, both currents showed
similar sensitivity to block by tetraethylammonium and CTX
(unpublished data). These results suggest normal functional
expression of Kv1.3 channels in the SCID T cells.
Consistent with these results, Kv1.3 transcript levels did
not differ significantly between patient and control T cells
(Fig. S4 A, available at http://www.jem.org/cgi/content/
full/jem.20050687/DC1). Kv1.3 protein was detected
readily in patient and control T cells by immunoblotting
(Fig. 4S B) and at the cell surface by immunocytochemistry
using Kv1.3-specific antibodies (Fig. 4S C, top panels). Flow
cytometric measurements of surface binding of fluorescently
labeled ShK-F6CA (42) confirmed equivalent surface ex-
pression of Kv1.3 in SCID and control T cells (Fig. 4S C,
lower panel).   subunits associated with Kv1.3, including
Kv 1, Kv 2, and Kv 3, also were expressed normally at the
mRNA and protein level (Fig. 4S, A and B).
Kv1.3 channel activation is altered in SCID T cells
Although the expression, inactivation, and pharmacologic
profile of Kv1.3 channels was normal in the SCID patient
cells, further examination revealed abnormal voltage depen-
dence and kinetics of channel activation. Kv1.3 current in
SCID cells showed a normal threshold for activation (ap-
proximately  50 mV), but the voltage dependence of chan-
nel activation was reduced markedly, as indicated by the di-
minished slope of the conductance-voltage relation (Fig. 7
A). The K  conductance increases e-fold per 11 mV in the
SCID cells relative to e-fold per 6 mV in controls, effectively
shifting the voltage for half-maximal activation by  12 mV.
Altered voltage sensitivity of Kv1.3 channels in the patient
cells was accompanied by slower than normal activation and
deactivation kinetics (Fig. 7, B and C). These changes in gat-
ing seem to be restricted to activation and deactivation; the
rate of C-type inactivation of Kv1.3 currents in SCID T cells
was normal (Fig. 7 D), consistent with their normal cumula-
tive inactivation characteristics (Fig. 6 C).
DISCUSSION
Here we have identified the underlying basis of the extensive
signaling defects in T cells from patients with a rare form of
SCID. Previous results revealed a profound lack of TCR-
mediated Ca2  influx in these cells, resulting in compro-
mised activation of the phosphatase calcineurin; diminished
nuclear translocation of the transcription factor NFAT; and
ultimately, the aberrant expression of  100 activation-asso-
Figure 6. Expression of Ca2 -activated and voltage-gated K  
channels in SCID T cells. (A) Amplitude of IKCa1 is normal in SCID cells 
internally dialyzed with 2  M Ca2 . IKCa1 current density measured from 
CTX-inhibited currents at  100 mV is plotted for control (n   5 cells) and 
SCID (n   7 cells) T cells (right). (B) Voltage-dependent K  currents in 
control (top) and SCID T cells (bottom), elicited by depolarizations from 
 70 to  70 mV in steps of 10 mV. The inset compares peak K  current 
densities at  70 mV in control (n   5 cells) and SCID (n   8 cells) T cells. 
(C) Cumulative inactivation of Kv1.3 current, elicited by steps to  60 mV 
applied every 1 s. Top: the first 10 responses to this protocol in a SCID cell. 
Bottom: average peak currents during successive pulses in control (closed 
circles; n   4 cells) and SCID cells (open circles: n   5 cells), relative to 
the first pulse. (D) Inhibition by ShK-Dap22. K  current in response to a 
pulse to  60 mV was blocked by 200 pM ShK-Dap22 in a SCID T cell (top). 
The degree of block is compared for control (n   4) and SCID (n   5) 
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ciated genes (8, 19). However, the precise nature of the
Ca2  influx defect was unknown, and several explanations
for the phenotype were possible. We have shown here that
TCR engagement or TG causes a normal amount of store
depletion in the SCID cells, and hence, the influx defect
does not seem to result from aberrant Ca2  store regulation.
In addition, expression of voltage-gated and Ca2 -activated
K  channels is normal, so that membrane depolarization and
a reduced driving force for Ca2  entry also is not a likely
mechanism. Using patch-clamp recording, we provide the
first direct evidence that the CRAC channels in the SCID T
cells are not functional. CRAC-mediated currents were un-
detectable, even under conditions that offer the greatest sen-
sitivity for detection (i.e., TG to deplete stores fully; a highly
hyperpolarized potential to maximize driving force; a low
concentration of 2-APB to enhance activity; and divalent-
free extracellular conditions to enable Na  to permeate, and
thereby, boost channel conductance). These measurements
show unequivocally that the Ca2  signaling defect in the
cells is due to a failure of CRAC channels to open.
Importantly, these results also confirm the essential role
of the CRAC channel in mediating Ca2  influx in response
to TCR stimulation. A recent study proposed that CaV
channels underlie TCR-mediated Ca2  entry in murine T
cells (13), based on the endogenous expression of   and  
subunits of L-type Ca2  channels and depolarization-acti-
vated L-type Ca2  currents in normal T cells, as well as ab-
normally small Ca2  signals in response to TCR stimulation
in mutant mice lacking the  4 subunit of the Ca2  channel.
These results are surprising considering that voltage-gated
Ca2  currents in T cells have not been detectable in a large
number of electrophysiological studies, and membrane de-
polarization has never been shown to elevate [Ca2 ]i in T
cells. In addition, it is not clear whether TCR cross-linking
activates CaV channels. In the study by Badou et al. (13),
anti-TCR antibodies evoked current fluctuations after an ar-
tificially imposed membrane depolarization but not at the
cell’s natural membrane potential. Finally, although normal
and SCID human T cells express several isoforms of the CaV
 1 subunit, thorough tests failed to reveal any Ca2  current
in response to depolarization before or after TCR stimula-
tion (unpublished data). Further work is needed to under-
stand the role of CaV channel proteins in human T cells, and
to explore additional functions of the   subunits. In contrast,
the absence of ICRAC in SCID T cells clearly supports the
idea that voltage-independent CRAC channels are the ma-
jor, if not the sole, pathway for Ca2  entry in response to
stimulation through the TCR (43). Such a role also is con-
sistent with previous studies of human SCID T cells (6, 7)
and CRAC-deficient mutant Jurkat T cells (27, 44), in
which a lack of CRAC channel activity was associated with
the absence of TCR-mediated Ca2  influx and deficient ac-
Figure 7. Voltage dependence and kinetics of Kv1.3 activation 
and deactivation are altered in SCID T cells. (A) The voltage sensitivity 
of Kv1.3 conductance in SCID cells is reduced. Kv1.3 conductance was 
measured from tail currents as described (see Materials and methods). 
Boltzmann curves were fitted and normalized to maximal conductance 
using the parameter values Gmax   8.85 nS, V1/2    43.9 mV, and k   6 mV 
(control) or Gmax   8.67 nS, V1/2    31.6 mV, and k   11 mV (SCID). 
(B) Activation kinetics of Kv1.3 current are slowed in SCID T cells. Currents 
evoked by pulses from  50 to  30 mV in control (black) and SCID T cells 
(red) are normalized to peak current at each voltage and superimposed 
(left). Activation kinetics were quantified by fitting single exponential 
functions to the final part of the rising phase of each current (right). 
(C) Deactivation kinetics are slowed in SCID cells. Normalized tail currents 
from a control (black) and a SCID T cell (red) upon repolarization to voltages 
of  100 to  50 mV (excluding  90 mV) after a 200-ms step to  60 mV 
are shown (left). Deactivation kinetics were measured from single expo-
nential fits to each tail current (right). (D) Slow C-type inactivation of 
Kv1.3 current is not altered in SCID T cells. Currents from control (top) 
and SCID T cells (bottom) in response to 500-ms steps from  10 mV to 
 80 mV are shown (left). The extent of inactivation at the end of each 
pulse (right) is similar for control (black; n   4 cells) and SCID cells (red; 
n   5 cells).JEM VOL. 202, September 5, 2005 659
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tivation of transcriptional pathways, cytokine secretion, and
T cell activation.
The molecular basis of store-operated Ca2  entry is one
of the enduring mysteries of cell biology. Despite more than
a decade of work by many laboratories focused on this ques-
tion, little is known about the nature of the CRAC channel
or its activation mechanism at a molecular level. Many genes
and mechanisms have been proposed, but supporting evi-
dence for many of these has been inconsistent. Of the TRP
channels that have been suggested as candidates for CRAC
channel subunits (TRPC1, TRPC3, TRPV6), we found
that all were expressed in the SCID cells and did not display
mutations, and that overexpression of TRPV6 was unable to
rescue store-operated Ca2  entry. The possible role of
TRPV6 in CRAC channel formation is controversial. Early
work indicated that TRPV6 shares several characteristic
properties with CRAC, such as divalent cation selectivity,
inactivation, and sensitivity to La3  (11). In addition, over-
expression of a dominant negative TRPV6 pore mutant was
able to suppress endogenous ICRAC in Jurkat cells (12); to-
gether, these studies supported the view that TRPV6 may
encode at least part of the CRAC channel pore. However,
other studies have shown differences with CRAC in terms
of ion selectivity and rectification, effects of intracellular
Mg2  and 2-APB (15), and unitary conductance (25); fur-
thermore, knockdown of TRPV6 with antisense or RNAi
methods fails to reduce ICRAC in RBL cells (45). Given the
evidence that the SCID cells may bear a defect in the
CRAC channel activation mechanism, our experiments do
not exclude a role for TRPV6 in CRAC-mediated Ca2  in-
flux in normal lymphocytes; however, we reasonably can
exclude their causative involvement in the CRAC defi-
ciency in the SCID patients.
Which aspect of the CRAC channel activation process is
deficient in the SCID T cells? The cells display a small
amount of CRAC channel activity, identified by its store
dependence and sensitivity to block by 2-APB, Gd3 , La3 ,
and SKF 96365; the properties of this residual Ca2  influx
can offer clues about the underlying defect. One possibility is
that the CRAC channel is not expressed at the cell surface,
because of a mutation affecting ion conduction, a defective
promoter, or mutations interfering with transport and traf-
ficking to the plasma membrane. If this were the case, the
residual influx would represent a small number of normal
channels, or a normal number of channels with greatly re-
duced ion conduction activity. One would predict that the
activity of these channels would be enhanced by a low con-
centration of 2-APB (Fig. 3, E and F). This was not ob-
served, arguing against the presence of a small number of
otherwise normal CRAC channels in the plasma membrane.
An alternative explanation for this result is that the SCID
cells harbor a defect in the CRAC channel activation process
which impairs channel activity as well as the ability of
2-APB to enhance it. Recent evidence suggests that 2-APB
inhibits several members of the TRP channel family by in-
terfering with channel activation rather than blocking chan-
nel conduction itself. For example, 2-APB inhibits currents
through  Drosophila TRP channels activated by light or
through mammalian TRPC3 channels activated by PLC-
coupled receptors, but does not affect the same channels
after they are activated directly by metabolic stress or diacyl-
glycerol, respectively (46, 47). A defect in the activation ma-
chinery also may explain why store-operated Ca2  influx
was not observed in SCID T cells transfected with TRPV6.
A defect in CRAC channel activation could occur at many
levels between store depletion and channel opening, includ-
ing the ER Ca2  sensor, the proteins that communicate store
depletion to the channel, and the ability of the CRAC chan-
nel itself to respond to the activation signal. Therefore, suc-
cessful complementation of the SCID cells may reveal cru-
cial information about the nature of the link between store
depletion and channel activation, as well as the molecular
mechanism of CRAC channel potentiation by 2-APB.
The expression and gross properties of several other
channels (TRPM7, Kv1.3, and IKCa1) were normal in the
SCID cells, suggesting that the mutation in the SCID cells
specifically targets CRAC channel activation rather than
channel expression, in general. However, we were surprised
to find that the activation kinetics and voltage sensitivity of
Kv1.3 are altered; the voltage sensitivity is reduced from a
normal value of 6 mV per e-fold change in conductance to
11 mV, with a slowing of channel activation and deactiva-
tion. There are several ways in which Kv1.3 channels are
known to be modulated in vivo. Association with   subunits
promotes cell surface expression of the Kv1.3   subunit, and
thereby, increases current amplitude without altering the
channel’s voltage dependence or activation kinetics (48).
Given that Kv1.3 current amplitude, cell surface expression
of Kv1.3 (Fig. S4 C), and Kv 1 and Kv 2 expression are
normal in the SCID T cells, a   subunit defect seems un-
likely. Phorbol ester shifts the voltage dependence of Kv1.3
in T cells toward positive voltages but without the large de-
crease in voltage sensitivity (as indicated by the slope of the
conductance-voltage curve) we have observed in SCID cells
(49). Likewise, expression of v-src is known to cause a similar
shift in voltage dependence without reducing voltage sensi-
tivity, and also greatly slows the rate of inactivation, which
also differs from the behavior of Kv1.3 in SCID cells (50).
Thus, it seems unlikely that the abnormal K  channel prop-
erties observed in SCID T cells are simply due to altered
phosphorylation by protein kinase C or a tyrosine kinase.
The association of altered K  channel kinetics with the
lack of CRAC channel activity in SCID T cells suggests a
functional link between CRAC and Kv channels. Although
further work is needed to establish the nature of this link,
one intriguing possibility is that Kv1.3 and CRAC channels
are regulated by a common protein which is targeted by the
SCID mutation. This protein target could be involved in
posttranslational modification of both channels or could be a
common subunit, adaptor, or scaffolding protein, which
could influence clustering or activation of CRAC and
Kv1.3. The PMCA and Kv1.3 bind to the scaffold MAGUKCRAC CHANNEL DEFECT IN SCID T CELLS | Feske et al. 660
protein SAP97 (hDlg) present in T cells (51, 52), and the
sensitivity of PMCA in T cells to local gradients of Ca2 
near CRAC channels suggests that CRAC and PMCA are
in close proximity to each other (53). These results raise the
possibility that SAP97 may bring CRAC, PMCA, and
Kv1.3 together in a multiprotein complex. Preliminary re-
sults suggest that the expression and localization of SAP97
are normal in SCID T cells and fibroblasts (unpublished
data); thus, the SCID phenotype does not seem to involve a
loss or gross mistargeting of SAP97. Further studies to exam-
ine the physical association of Kv1.3 with CRAC channels
and other proteins in T cells may offer a new strategy for un-
derstanding the regulation of store-operated Ca2  entry.
MATERIALS AND METHODS
Cells. Continuously growing T cell lines were derived from the peripheral
blood lymphocytes of two patients and four healthy donors (22). Foreskin fi-
broblasts from newborn SCID patient 2 and a healthy newborn (Hs27 cell
line, American Type Culture Collection) were immortalized by retroviral
transduction with a telomerase expression plasmid (hTERT, gift of S. Less-
nick, Dana-Farber Cancer Institute, Boston, MA). Patients in this study were
included in a human subjects protocol which was reviewed and approved by
the CBR Institute’s internal review board. The rhabdomyosarcoma cell line
TE671 was obtained from American Type Culture Collection.
Solutions and chemicals. Standard extracellular Ringer’s solution con-
tained (in mM): 155 NaCl, 4.5 KCl, 2 CaCl2, 1 MgCl2, 10 D-glucose, and
5 Na-Hepes (pH 7.4). In Ca2 -free Ringer’s, 1 mM EGTA   2 mM
MgCl2 was substituted for CaCl2. For measurements of ICRAC, 20 mM
CaCl2 was used. DVF Ringer’s solution contained (in mM): 155 Na meth-
anesulfonate, 10 HEDTA, 1 EDTA, and 10 Hepes (pH 7.4 with NaOH).
For measurements of KCa currents, NaCl in Ringer’s solution was replaced
with KCl. Internal solutions for recordings of ICRAC contained (in mM):
150 Cs methanesulfonate, 8 MgCl2, 10 BAPTA, and 10 Cs Hepes (pH 7.2).
For recordings of IMIC, internal solution contained (in mM): 150 Cs meth-
anesulfonate, 10 HEDTA, 0.5 CaCl2 and 10 Cs-Hepes (pH 7.2). For re-
cordings of KCa current, internal solution contained (in mM): 150 K aspar-
tate, 2 MgCl2, 10 K Hepes, 10 EGTA, and added CaCl2 to yield a free
[Ca2 ] of 2  M. For recordings of Kv1.3 current, internal solution con-
tained (in mM): 150 K aspartate 4 MgCl2, 10 EGTA, and 10 K Hepes. pH
of all internal solutions was 7.2. Solutions were applied to the cells with a
rapid multi-barrel local perfusion pipette (25). 2-APB was purchased from
Sigma-Aldrich and TG was purchased from LC Biochemicals.
Cell extracts, immunoblotting, and immunocytochemistry. Prepa-
ration of total cellular extracts, immunoblotting, and immunocytochemistry was
done as described (19) (see supplemental Materials and methods, available
at http://www.jem.org/cgi/content/full/jem.20050687/DC1). Antibodies
against STIM1 were obtained from BD Biosciences and as a gift of G. Veli-
celebi (Torrey Pines Therapeutics, La Jolla, CA). Antibody against calreticulin
was purchased from Abcam (Cambridge, MA). For overexpression of STIM1,
full-length STIM1 (NM_003156) cDNA (Openbiosystems) was subcloned into
pENTR11 (Gateway system, Invitrogen) and transferred into MSCV-contain-
ing retroviral destination vector GFP-KV-DV for stable transduction of fibro-
blasts essentially as described (54). Immunocytochemical analysis was performed
on an Axiovert S200 epifluorescence microscope (Carl Zeiss Microimaging,
Inc.) with Openlab digital imaging software (Improvision); deconvolution
of z-sections was performed to subtract out-of-focus signals.
Single-cell Ca2  imaging. T cells were loaded with 1  M fura-2/AM
(Molecular Probes) in RPMI 1640   10% FBS for 30 min at 22–25 C, and
fibroblasts grown directly on UV-sterilized cover slips were loaded with 3
 M fura-2/AM for 45 min at 22–25 C. Ca2  imaging was done with a
Zeiss Axiovert S200 epifluorescence microscope and OpenLab imaging
software (Improvision) as described (8). To actively deplete Ca2  stores, T
cells were incubated with 5  g/ml biotinylated anti-CD3 antibody
(UCHT1, BD Biosciences) for 10 min at 22–25 C followed by cross-link-
ing with 5  g/ml streptavidin (Pierce Chemical Co.).
Patch-clamp electrophysiology. Whole-cell recording was conducted
at 22–25 C using standard methods (25). Currents were filtered at 1 or 2
kHz with a 4-pole Bessel filter and sampled at 5 kHz. For measurements of
CRAC and MIC currents, a voltage protocol consisting of a 100-ms step to
 110 mV followed by a ramp from  110 to  90 mV lasting 100 ms was
applied. Voltage pulses were delivered at 1-s intervals from a holding poten-
tial of  20 mV. Unless noted otherwise, all data were corrected for liquid
junction potential of the pipette solution and for leak currents collected in
Ca2 -free Ringer’s solution; averaged results are presented as the mean
value   SEM.
IKCa1 currents were measured by stepping the voltage to  100 mV for
100 ms followed by a ramp from  100 to  100 mV for 100 ms. For measure-
ments of Kv1.3 currents, voltage pulses were delivered every 15–20 s from a
holding potential of  80 mV, and currents were leak subtracted using the P/8
method with an offset of  20 mV. For conductance-voltage curves, tail cur-
rents were measured 200  s after membrane repolarization. Curves were fit
with a Boltzmann function: G(V)   Gmax/{1   exp[(V-V1/2/k)]}, where Gmax
is the maximal conductance, V1/2 is the voltage for half-maximal activation,
and k is the voltage sensitivity in mV.
Online supplemental material.  Fig. S1 shows evidence that expression
levels of IP3 receptors and PLC  are similar in control and SCID T cells. Fig.
S2 quantitates store-operated Ca2  influx in individual SCID T cells and
shows that it is inhibited by 2-APB. Fig. S3 shows that expression levels of
mRNA for TRPC1-5, TRPC7, TRPV5, and TRPV6 in SCID T cells are
all within normal range. Fig. S4 shows evidence that protein expression of
Kv1.3 and it’s   subunits are normal in SCID calls, as are mRNA levels for
Kv1.3, IKCa1, Kv3.1, and Kv 1,  2, and  3. Online supplemental material
is available at http://www.jem.org/cgi/content/full/jem.20050687/DC1.
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